drugset / Trial / NCT01096745
Randomized Trial of Gemcitabine/Cisplatin Versus S-1/Cisplatin in Advanced Biliary Cancer
Phase 2
Terminated
78 enrolled
Gyeongsang National University Hospital
Chung-Ang University · collabDong-A University · collabSamsung Medical Center · collab
RandomizedParallel-groupOpen-labelTreatment
Summary
The purpose of this study is to compare the efficacy between gemcitabine/cisplatin and S-1/cisplatin in the first-line treatment in advanced biliary tract cancer.
Timeline
- Start
- 2010-07
- Primary completion
- 2013-03
- Completion
- 2013-09
Outcome
Outcome not reported
Stopped: “Planning for randomized phase III trial for this issue.”
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Gemcitabine | Small molecule | 1000 mg/m2 | — |
| Subject | S-1 | Small molecule | 40 mg/m2 | Oral |
| Background | Cisplatin | Other / unclassified | 25 unknown | — |